The circadian system of patients with bipolar disorder differs in episodes of mania and depression

Bipolar Disorders

Volumn 17, Issue 3, 2015, Pages 303-314

  Nováková, Marta ^a   Praško, Ján ^b   Látalová, Klára ^b   Sládek, Martin ^a   Sumová, Alena ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Nr1d1; Bipolar disorder; Circadian; Clock gene; Melatonin; Per1

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; CLONAZEPAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; LAMOTRIGINE; LEVOMEPROMAZINE; LITHIUM; MELATONIN; MOOD STABILIZER; OLANZAPINE; OXAZEPAM; QUETIAPINE; RISPERIDONE; VALPROIC ACID; VENLAFAXINE; CIRCADIAN RHYTHM SIGNALING PROTEIN; MESSENGER RNA; NR1D1 PROTEIN, HUMAN; NUCLEAR RECEPTOR NR1D1; PER1 PROTEIN, HUMAN; TRANSCRIPTOME;

ADULT; ARTICLE; BIPOLAR DISORDER; CHEEK MUCOSA; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAY LENGTH; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL STATUS; GENE; GENE EXPRESSION PROFILING; HUMAN; HYPOTHESIS; MALE; MANIA; MENTAL PATIENT; MOLECULAR CLOCK; NR1D1 GENE; PER1 GENE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SALIVA; SLEEP WAKING CYCLE; TREND STUDY; CASE CONTROL STUDY; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGY; SLEEP DISORDER;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHRONOBIOLOGY DISORDERS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; MOUTH MUCOSA; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; PERIOD CIRCADIAN PROTEINS; PREVALENCE; RNA, MESSENGER; SALIVA; TRANSCRIPTOME;

EID: 84928113796     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12270     Document Type: Article

References (67)

1. Boland EM, Alloy LB. Sleep disturbance and cognitive deficits in bipolar disorder: toward an integrated examination of disorder maintenance and functional impairment. Clin Psychol Rev 2013; 33: 33-44.
2. Kripke DF, Mullaney DJ, Atkinson M, Wolf S. Circadian rhythm disorders in manic-depressives. Biol Psychiatry 1978; 13: 335-351.
3. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 2008; 165: 820-829.
4. Borbély AA, Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms 1999; 14: 557-568.
5. Stratmann M, Schibler U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J Biol Rhythms 2006; 21: 494-506.
6. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 2010; 72: 517-549.
7. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008; 9: 764-775.
8. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003; 4: 649-661.
9. Barnard AR, Nolan PM. When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet 2008; 4: e1000040.
10. Kennedy SH, Kutcher SP, Ralevski E, Brown GM. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res 1996; 63: 219-222.
11. Cervantes P, Gelber S, Kin FN, Nair VN, Schwartz G. Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci 2001; 26: 411-416.
12. Yang S, Van Dongen HP, Wang K, Berrettini W, Bućan M. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry 2009; 14: 143-155.
13. Robillard R, Naismith SL, Rogers NL et al. Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. Eur Psychiatry 2013; 28: 412-416.
14. McCarthy MJ, Wei H, Marnoy Z et al. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl Psychiatry 2013; 22: e318.
15. Illnerová H. The suprachiasmatic nucleus and rhythmic pineal melatonin production. In: Klein DC, Moore RJ, Reppert SM eds. Suprachiasmatic Nucleus: The Mind's Clock. New York, NY: Oxford University Press, 1991: 197-216.
16. Illnerová H, Sumová A. Photic entrainment of the mammalian rhythm in melatonin production. J Biol Rhythms 1997; 12: 547-555.
17. Arendt J. Melatonin and human rhythms. Chronobiol Int 2006; 23: 21-37.
18. Milhiet V, Etain B, Boudebesse C, Bellivier F. Circadian biomarkers, circadian genes and bipolar disorders. J Physiol Paris 2011; 105: 183-189.
19. Milhiet V, Boudebesse C, Bellivier F, Drouot X, Henry C, Leboyer MEB. Circadian abnormalities as markers of susceptibility in bipolar disorders. Front Biosci (Schol Ed) 2014; 1: 120-137.
20. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: National Institute of Mental Health, US Department of Heath, Education, and Welfare Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 1976.
21. Lecrubier Y, Sheehan D, Weiller E et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 224-231.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
23. Young RC, Biggs JT, Zeigler VE, Meyer DA. A rating scale for mania: relieability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
24. Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis 1986; 174: 727-735.
25. Waller NG, Ross CA. The prevalence and biometric structure of pathological dissociation in the general population: taxometric and behavior genetic findings. J Abnorm Psychol 1997; 106: 499-510.
26. Nováková M, Paclt I, Ptáček R, Kuželová H, Hájek I, Sumová A. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder. Chronobiol Int 2011; 28: 630-637.
27. Nováková M, Nevšímalová S, Příhodová I, Sládek M, Sumová A. Alteration of the circadian clock in children with Smith-Magenis syndrome. J Clin Endocrinol Metab 2012; 97: E312-E318.
28. Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinor-rhythmometry. Chronobiologia 1979; 6: 305-323.
29. Illnerová H, Vaněček J, Hoffmann K. Different mechanisms of phase delays and phase advances of the circadian rhythm in rat pineal N-acetyltransferase activity. J Biol Rhythms 1989; 4: 187-200.
30. Lewy AJ, Nurnberger JI, Wehr TA et al. Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry 1985; 142: 725-727.
31. Lam RW, Berkowitz AL, Berga SL, Clark CM, Kripke DF, Gillin JC. Melatonin suppression in bipolar and unipolar mood disorders. Psychiatry Res 1990; 33: 129-134.
32. Nurnberger JI, Adkins S, Lahiri DK et al. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry 2000; 57: 572-579.
33. Kennedy SH, Tighe S, McVey G, Brown GM. Melatonin and cortisol "switches" during mania, depression, and euthymia in a drug-free bipolar patient. J Nerv Ment Dis 1989; 177: 300-303.
34. Leibenluft E, Feldman-Naim S, Turner EH, Schwartz PJ, Wehr TA. Salivary and plasma measures of dim light melatonin onset (DLMO) in patients with rapid cycling bipolar disorder. Biol Psychiatry 1996; 40: 731-735.
35. Potocki L, Glaze D, Tan DX et al. Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome. J Med Genet 2000; 37: 428-433.
36. De Leersnyder H, De Blois MC, Claustrat B et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr 2001; 139: 111-116.
37. De Leersnyder H, Bresson JL, De Blois MC et al. Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J Med Genet 2003; 40: 74-78.
38. De Leersnyder H, Claustrat B, Munnich A, Verloes A. Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome. Mol Cell Endocrinol 2006; 252: 88-91.
39. Williams SR, Zies D, Mullegama SV, Grotewiel MS, Elsea SH. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet 2012; 90: 941-949.
40. Gouin JP, Connors J, Kiecolt-Glaser JK et al. Altered expression of circadian rhythm genes among individuals with a history of depression. J Affect Disord 2010; 126: 161-166.
41. Li SX, Liu LJ, Xu LZ et al. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology 2013; 38: 2789-2799.
42. Li JZ, Bunney BG, Meng F et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci USA 2013; 110: 9950-9955.
43. Easton A, Arbuzova J, Turek FW. The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav 2003; 2: 11-19.
44. Roybal K, Theobold D, Graham A et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007; 104: 6406-6411.
45. Van Enkhuizen J, Minassian A, Young JW. Further evidence for ClockΔ19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating. Behav Brain Res 2013; 249: 44-54.
46. McCarthy MJ, Nievergelt CM, Kelsoe JR, Welsh DK. A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS ONE 2012; 7: e32091.
47. Mansour HA, Wood J, Chowdari KV et al. Circadian phase variation in bipolar I disorder. Chronobiol Int 2005; 22: 571-584.
48. Ahn YM, Chang J, Joo YH, Kim SC, Lee KY, Kim YS. Chronotype distribution in bipolar I disorder and schizophrenia in a Korean sample. Bipolar Disord 2008; 10: 271-275.
49. Wood J, Birmaher B, Axelson D et al. Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals. Psychiatry Res 2009; 166: 201-209.
50. Nováková M, Sládek M, Sumová A. Human chronotype is determined in bodily cells under real-life conditions. Chronobiol Int 2013; 30: 607-617.
51. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-8459.
52. Ryves WJ, Harwood AJ. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 2001; 280: 720-725.
53. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 2006; 311: 1002-1005.
54. Hirota T, Lewis WG, Liu AC, Lee JW, Schultz PG, Kay SA. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc Natl Acad Sci USA 2008; 105: 20746-20751.
55. Li J, Lu WQ, Beesley S, Loudon ASI, Meng QJ. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS ONE 2012; 7: e33292.
56. Kim SH, Yu HS, Park HG et al. Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene. Biochim Biophys Acta 2013; 1832: 1969-1979.
57. Hallam KT, Olver JS, Norman TR. Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers. Neuropsychopharmacology 2005; 30: 1400-1404.
58. Dokucu ME, Yu L, Taghert PH. Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuropsychopharmacology 2005; 30: 2216-2224.
59. Johansson A-S, Brask J, Owe-Larsson B, Hetta J, Lundkvist GBS. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase. J Biol Rhythms 2011; 26: 541-551.
60. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans. Chronobiol Int 1993; 10: 205-213.
61. Monteleone P, Forziati D, Orazzo C, Maj M. Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J Pineal Res 1989; 6: 253-258.
62. Wakabayashi H, Shimada K, Satoh T. Effects of diazepam administration on melatonin synthesis in the rat pineal gland in vivo. Chem Pharm Bull 1991; 39: 2674-2676.
63. Djeridane Y, Touitou Y. Effects of diazepam and its metabolites on nocturnal melatonin secretion in the rat pineal and Harderian glands. A comparative in vivo and in vitro study. Chronobiol Int 2003; 20: 285-297.
64. Carvalho LA, Gorenstein C, Moreno R, Pariante C, Markus RP. Effect of antidepressants on melatonin metabolite in depressed patients. J Psychopharmacol 2009; 23: 315-321.
65. Tan Z-L, Bao A-M, Zhao G-Q, Liu Y-J, Zhou J-N. Effect of fluoxetine on circadian rhythm of melatonin in patients with major depressive disorder. Neuro Endocrinol Lett 2007; 28: 28-32.
66. Sprouse J, Braselton J, Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol Psychiatry 2006; 60: 896-899.
67. Gannon RL, Millan MJ. Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms. Psychopharmacology 2007; 195: 325-332.